Nocebo responses to antihypertensive medications.

J Clin Hypertens (Greenwich)

Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI, USA.

Published: September 2008

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673219PMC
http://dx.doi.org/10.1111/j.1751-7176.2008.00007.xDOI Listing

Publication Analysis

Top Keywords

nocebo responses
4
responses antihypertensive
4
antihypertensive medications
4
nocebo
1
antihypertensive
1
medications
1

Similar Publications

Placebo and the law of identification.

Front Psychiatry

December 2024

College of Medicine, University of Arizona, Tucson, AZ, United States.

Thousands of essays and studies have been published on placebo and nocebo. Yet, despite this plethora of information, we are not much closer to a comprehensive understanding of the fundamental mechanism producing placebo and nocebo effects than we were in 1946, when participants in the Cornell Conferences on Therapy speculated on the roles of authority, belief and expectancy. In this paper, we examine the weaknesses in current placebo and nocebo definitions and theories.

View Article and Find Full Text PDF

Objective: Randomized controlled trials (RCTs) are necessary to evaluate the efficacy of novel treatments for epilepsy. However, there have been concerning increases in the placebo responder rate over time. To understand these trends, we evaluated features associated with increased placebo responder rate.

View Article and Find Full Text PDF

Trait responsiveness to verbal suggestions predicts nocebo responding: A meta-analysis.

Br J Health Psychol

February 2025

Department of Psychology, Institute of Psychology, Psychiatry, and Neuroscience, King's College London, London, UK.

Background: Nocebo responding involves the experience of adverse health outcomes in response to contextual cues. These deleterious responses impact numerous features of mental and physical health but are characterized by pronounced heterogeneity. Suggestion is widely recognized as a contributing factor to nocebo responding but the moderating role of trait responsiveness to verbal suggestions (suggestibility) in nocebo responding remains poorly understood.

View Article and Find Full Text PDF

Placebo hypoalgesia and nocebo hyperalgesia, which exemplify the impact of expectations on pain, have recently been conceptualised as Bayesian inferential processes, yet empirical evidence remains limited. Here, we explore whether these phenomena can be unified within the same Bayesian framework by testing the predictive role of expectations and their level of precision (ie, expectation confidence) on pain, with both predictors measured at the metacognitive level. Sixty healthy volunteers underwent a pain test (ie, 8 noxious electrical stimuli) before (Baseline) and after (T0, T1, T2) receiving a sham treatment associated with hypoalgesic (placebo), hyperalgesic (nocebo), or neutral (control) verbal suggestions, depending on group allocation.

View Article and Find Full Text PDF

A mechanistic understanding of human magnetoreception validates the phenomenon of electromagnetic hypersensitivity (EHS).

Int J Radiat Biol

December 2024

Independent Scientist, Brambling, Beeswing, Dumfries, Scotland, UK.

Background: Human electromagnetic hypersensitivity (EHS) or electrosensitivity (ES) symptoms in response to anthropogenic electromagnetic fields (EMFs) at levels below current international safety standards are generally considered to be nocebo effects by conventional medical science. In the wider field of magnetoreception in biology, our understanding of mechanisms and processes of magnetic field (MF) interactions is more advanced.

Methods: We consulted a range of publication databases to identify the key advances in understanding of magnetoreception across the wide animal kingdom of life.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!